Answers are grounded in this paper and cite their sources.
Protein misfolding plays a fundamental role in the onset of numerous cellular pathologies. Among these, alpha-synuclein (α-syn) misfolding is central to the pathogenesis of both neurodevelopmental and neurodegenerative disorders. The SH-SY5Y human neuroblastoma cell line serves as a valuable model to recapitulate α-syn misfolding observed in vivo, offering insight into various therapeutic strategies. Despite intensive research, no intervention has yet proven to be consistently safe, effective, and reproducible in preventing α-syn misfolding. This review explores the mechanistic underpinnings of α-syn pathology including endoplasmic reticulum (ER) stress, mitochondrial dysfunction, and gut microbiome dysbiosis and introduces exopolysaccharide β-glucans as promising, multifaceted therapeutic agents. Especially focussing on those 1-3,1-6 β-glucans from the polyextremotolerant yeast Aureobasidium pullulans, which have shown potential in modulating the gut-brain axis, reducing inflammation, promoting epigenetic stability, and facilitating the clearance of aggregated α-syn. Their broad-spectrum biological response-modifying activities could form the basis for novel adjunctive therapies aimed at neurodegenerative and neurodevelopmental conditions.
No takes yet. Share an insight, caveat, or question.
Ikewaki et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: